These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32533514)

  • 1. Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents.
    Veeravarapu H; Malkhed V; Mustyala KK; Vadija R; Malikanti R; Vuruputuri U; Muthyala MKK
    Mol Divers; 2021 Feb; 25(1):351-366. PubMed ID: 32533514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, antimycobacterial activity and molecular docking studies of novel 3- (N-substituted glycinamido) benzoic acid analogues as anti tubercular agents.
    Veeravarapu H; Tirumalasetty M; Kurati S; Wunnava U; Krishna Kumar Muthyala M
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127603. PubMed ID: 33039564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Taira J; Ito T; Nakatani H; Umei T; Baba H; Kawashima S; Maruoka T; Komatsu H; Sakamoto H; Aoki S
    Int J Mycobacteriol; 2017; 6(2):142-148. PubMed ID: 28559515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach.
    Sharma A; Islam MH; Fatima N; Upadhyay TK; Khan MKA; Dwivedi UN; Sharma R
    Mol Biol Rep; 2019 Apr; 46(2):1715-1725. PubMed ID: 30715689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents.
    Sharma K; Tanwar O; Sharma S; Ali S; Alam MM; Zaman MS; Akhter M
    Bioorg Chem; 2018 Oct; 80():319-333. PubMed ID: 29986181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold.
    Zhang D; Lin Y; Chen X; Zhao W; Chen D; Gao M; Wang Q; Wang B; Huang H; Lu Y; Lu Y
    Bioorg Chem; 2019 Apr; 85():229-239. PubMed ID: 30641319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and mechanistic comparison of the Cyclopropane Mycolic Acid Synthases (CMAS) protein family of Mycobacterium tuberculosis.
    Defelipe LA; Osman F; Marti MA; Turjanski AG
    Biochem Biophys Res Commun; 2018 Mar; 498(2):288-295. PubMed ID: 28859976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-adenosyl-N-decyl-aminoethyl, a potent bisubstrate inhibitor of mycobacterium tuberculosis mycolic acid methyltransferases.
    Vaubourgeix J; Bardou F; Boissier F; Julien S; Constant P; Ploux O; Daffé M; Quémard A; Mourey L
    J Biol Chem; 2009 Jul; 284(29):19321-30. PubMed ID: 19439410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure based virtual screening and discovery of novel inhibitors against FabD protein of
    Sundararajan S; Karunakaran K; Muniyan R
    J Biomol Struct Dyn; 2024 Aug; 42(12):6280-6291. PubMed ID: 37424186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
    Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
    Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
    Dkhar HK; Gopalsamy A; Loharch S; Kaur A; Bhutani I; Saminathan K; Bhagyaraj E; Chandra V; Swaminathan K; Agrawal P; Parkesh R; Gupta P
    J Biol Chem; 2015 Jan; 290(1):76-89. PubMed ID: 25384979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor binding studies of
    Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,3-Oxazine-2-one derived dual-targeted molecules against replicating and non-replicating forms of Mycobacterium tuberculosis.
    Velappan AB; Kesamsetty D; Datta D; Ma R; Hari N; Franzblau SG; Debnath J
    Eur J Med Chem; 2020 Dec; 208():112835. PubMed ID: 32977201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural modification of a novel inhibitor for mycobacterium enoyl-acyl carrier protein reductase assisted by
    Taira J; Nagano T; Kitamura M; Yamaguchi M; Sakamoto H; Aoki S
    Int J Mycobacteriol; 2020; 9(1):12-17. PubMed ID: 32474482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.